218 related articles for article (PubMed ID: 7913311)
1. [Atypical MDR].
Yokomizo A; Taniguchi K; Hasegawa S; Abe T; Kubo T; Makino Y; Wada M; Kohno K; Kuwano M
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1123-9. PubMed ID: 7913311
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D
Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors.
Beck WT
Cancer Treat Rev; 1990 Dec; 17 Suppl A():11-20. PubMed ID: 1982639
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance.
Moscow JA; Cowan KH
J Natl Cancer Inst; 1988 Mar; 80(1):14-20. PubMed ID: 2892943
[TBL] [Abstract][Full Text] [Related]
5. [Multidrug resistance (MDR)].
Wada M; Hasegawa S; Kohno K; Kuwano M
Gan To Kagaku Ryoho; 1994 Jun; 21(7):936-44. PubMed ID: 8002631
[TBL] [Abstract][Full Text] [Related]
6. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
7. Studies on low-level MDR cells.
Belvedere G; Dolfini E
Cytotechnology; 1993; 12(1-3):257-64. PubMed ID: 7765328
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic, multidrug-resistant phenotype and P-glycoprotein: a review.
Ban T
Chemotherapy; 1992; 38(3):191-6. PubMed ID: 1355045
[TBL] [Abstract][Full Text] [Related]
9. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
Nooter K; Stoter G
Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
[TBL] [Abstract][Full Text] [Related]
11. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.
Nathwani SM; Butler S; Fayne D; McGovern NN; Sarkadi B; Meegan MJ; Lloyd DG; Campiani G; Lawler M; Williams DC; Zisterer DM
Cancer Chemother Pharmacol; 2010 Aug; 66(3):585-96. PubMed ID: 20020128
[TBL] [Abstract][Full Text] [Related]
12. [Multidrug resistance of cancer cells mediated by ABC superfamily transporters].
Ueda K
Nihon Rinsho; 1997 May; 55(5):1024-9. PubMed ID: 9155147
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein and multidrug resistance in cancer chemotherapy.
Deuchars KL; Ling V
Semin Oncol; 1989 Apr; 16(2):156-65. PubMed ID: 2565605
[No Abstract] [Full Text] [Related]
14. Strategies to circumvent multidrug resistance due to P-glycoprotein or to altered DNA topoisomerase II.
Beck WT
Bull Cancer; 1990; 77(11):1131-41. PubMed ID: 1980425
[TBL] [Abstract][Full Text] [Related]
15. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
16. Reversing agents for ATP-binding cassette drug transporters.
Lee CH
Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
[TBL] [Abstract][Full Text] [Related]
17. Non-P-glycoprotein drug export mechanisms of multidrug resistance.
List AF
Semin Hematol; 1997 Oct; 34(4 Suppl 5):20-4. PubMed ID: 9408957
[TBL] [Abstract][Full Text] [Related]
18. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
[TBL] [Abstract][Full Text] [Related]
19. Genetic basis of multidrug resistance of tumor cells.
Kane SE; Pastan I; Gottesman MM
J Bioenerg Biomembr; 1990 Aug; 22(4):593-618. PubMed ID: 1977744
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of multidrug resistance to chemotherapy.
de Vries EG; Pinedo HM
Cancer Treat Res; 1991; 57():171-86. PubMed ID: 1686716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
